PHARMASSET INC. VRUS (NASDAQ) $ 13.01 Change: -1.76 -13.53% | Volume: 271,291
Sponsored by Click here!

PHARMASSET INC - Fundamental Profile

Company Information

Ticker Symbol: VRUS
Exchange: NASD
Contact Info:
CEO/President:
Industry: Medical - Drugs / Standard Industry Code:
Description: PHARMASSET INC is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus, hepatitis C virusand human immunodeficiency virus.

Share Information

Shares Outstanding: 21,590 (000) Market Value: 363,550 ($000)
Percentage of Inst.Shareholders: 46.84% Number of Inst.Shareholders: 14.50%
Last Quarter Sales: 0.46 ($Mil.) Last Quarter Net Income: -15.03 ($Mil.)
Last Quarter EPS: -0.69 P/E Ratio: 0
Most Recent Earnings: Earnings Per Share: -2.23
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement